Literature DB >> 16249381

Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division.

Bernd Giebel1, Tao Zhang, Julia Beckmann, Jan Spanholtz, Peter Wernet, Anthony D Ho, Michael Punzel.   

Abstract

It is often predicted that stem cells divide asymmetrically, creating a daughter cell that maintains the stem-cell capacity, and 1 daughter cell committed to differentiation. While asymmetric stem-cell divisions have been proven to occur in model organisms (eg, in Drosophila), it remains illusive whether primitive hematopoietic cells in mammals actually can divide asymmetrically. In our experiments we have challenged this question and analyzed the developmental capacity of separated offspring of primitive human hematopoietic cells at a single-cell level. We show for the first time that the vast majority of the most primitive, in vitro-detectable human hematopoietic cells give rise to daughter cells adopting different cell fates; 1 inheriting the developmental capacity of the mother cell, and 1 becoming more specified. In contrast, approximately half of the committed progenitor cells studied gave rise to daughter cells, both of which adopted the cell fate of their mother. Although our data are compatible with the model of asymmetric cell division, other mechanisms of cell fate specification are discussed. In addition, we describe a novel human hematopoietic progenitor cell that has the capacity to form natural killer (NK) cells as well as macrophages, but not cells of other myeloid lineages.

Entities:  

Mesh:

Year:  2005        PMID: 16249381     DOI: 10.1182/blood-2005-08-3139

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  On the probability of random genetic mutations for various types of tumor growth.

Authors:  Cristian Tomasetti
Journal:  Bull Math Biol       Date:  2012-02-07       Impact factor: 1.758

2.  New relationships of human hematopoietic lineages facilitate detection of multipotent hematopoietic stem and progenitor cells.

Authors:  André Görgens; Stefan Radtke; Peter A Horn; Bernd Giebel
Journal:  Cell Cycle       Date:  2013-10-23       Impact factor: 4.534

Review 3.  Divide and conquer: how asymmetric division shapes cell fate in the hematopoietic system.

Authors:  Kendra L Congdon; Tannishtha Reya
Journal:  Curr Opin Immunol       Date:  2008-06-12       Impact factor: 7.486

Review 4.  Epigenetic programming of mesenchymal stem cells from human adipose tissue.

Authors:  Andrew C Boquest; Agate Noer; Philippe Collas
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

5.  Epigenetic reprogramming induces the expansion of cord blood stem cells.

Authors:  Pratima Chaurasia; David C Gajzer; Christoph Schaniel; Sunita D'Souza; Ronald Hoffman
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

6.  The Stromal Activity of Mesenchymal Stromal Cells.

Authors:  Wolfgang Wagner; Rainer Saffrich; Anthony D Ho
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

Review 7.  Regulation of long-term repopulating hematopoietic stem cells by EPCR/PAR1 signaling.

Authors:  Shiri Gur-Cohen; Orit Kollet; Claudine Graf; Charles T Esmon; Wolfram Ruf; Tsvee Lapidot
Journal:  Ann N Y Acad Sci       Date:  2016-03-01       Impact factor: 5.691

8.  A hybrid agent-based model of the developing mammary terminal end bud.

Authors:  Joseph D Butner; Yao-Li Chuang; Eman Simbawa; A S Al-Fhaid; S R Mahmoud; Vittorio Cristini; Zhihui Wang
Journal:  J Theor Biol       Date:  2016-07-28       Impact factor: 2.691

9.  Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny.

Authors:  Rina Ashkenazi; Sara N Gentry; Trachette L Jackson
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

10.  Modeling of replicative senescence in hematopoietic development.

Authors:  Anna Marciniak-Czochra; Thomas Stiehl; Wolfgang Wagner
Journal:  Aging (Albany NY)       Date:  2009-07-23       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.